Association Between Reductions of Number of Cigarettes Smoked per Day and Mortality Among Older Adults in the United States.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 01 03 2018
accepted: 26 09 2018
pubmed: 10 10 2018
medline: 19 11 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

Many smokers do not quit but instead reduce the number of cigarettes they smoke per day (CPD) over their lifetime. Yet the associations of such changes in CPD with health risks are unclear. We examined the association of changes in CPD with subsequent death in the period 2004-2011 among 253,947 participants of the National Institutes of Health-AARP Diet and Health Study. Using a questionnaire assessing responders' history of smoking cigarettes, we identified cigarette smokers who quit, decreased, maintained, or increased their CPD between ages 25-29 and 50-59 years. Hazard ratios and 95% confidence intervals were obtained from multivariable adjusted Cox proportional hazards regression models. Relative to never smokers, smokers who maintained a consistent CPD had 2.93 times (95% confidence interval (CI): 2.82, 3.05) higher all-cause mortality risk, and participants who increased their CPD had still higher risk (hazard ratio (HR) = 3.37, 95% CI: 3.23, 3.52). Death risk was lower among participants who decreased their CPD (HR = 2.38, 95% CI: 2.25, 2.52) or quit smoking (for quitting between ages 30 and 39 years, HR = 1.32, 95% CI: 1.25, 1.39). Similar patterns were observed for smoking-related causes of death, with particularly strong associations for lung cancer and respiratory disease. Reductions in CPD over the lifetime meaningfully decreased death risk; however, cessation provided a larger benefit than even large declines in CPD.

Identifiants

pubmed: 30299454
pii: 5123984
doi: 10.1093/aje/kwy227
pmc: PMC6357806
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-371

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

JAMA. 2014 Jan 8;311(2):164-71
pubmed: 24399555
J Epidemiol Community Health. 2003 Jun;57(6):412-6
pubmed: 12775785
JAMA. 2016 Jun 7;315(21):2300-11
pubmed: 27179989
Am J Epidemiol. 2002 Dec 1;156(11):994-1001
pubmed: 12446255
JAMA Intern Med. 2017 Jan 1;177(1):87-95
pubmed: 27918784
Am J Epidemiol. 2013 Sep 1;178(5):770-9
pubmed: 23825165
N Engl J Med. 2013 Jan 24;368(4):341-50
pubmed: 23343063
Epidemiology. 1993 Sep;4(5):444-8
pubmed: 8399693
Am J Epidemiol. 2001 Dec 15;154(12):1119-25
pubmed: 11744517
J Clin Oncol. 2008 Nov 1;26(31):5101-6
pubmed: 18838704
Addiction. 2005 Aug;100(8):1074-89
pubmed: 16042638
Stroke. 2008 Sep;39(9):2432-8
pubmed: 18617660
Am J Public Health. 1989 Feb;79(2):200-2
pubmed: 2913842
Tob Control. 2006 Dec;15(6):472-80
pubmed: 17130377
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
BMJ. 1994 Oct 8;309(6959):901-11
pubmed: 7755693
JAMA. 2005 Sep 28;294(12):1505-10
pubmed: 16189363
Nicotine Tob Res. 2007 Jun;9(6):631-46
pubmed: 17558820
Health Psychol. 2003 May;22(3):245-52
pubmed: 12790251
Am J Epidemiol. 2012 May 15;175(10):1006-12
pubmed: 22306566
Vital Health Stat 10. 2014 Feb;(260):1-161
pubmed: 24819891
JAMA. 2008 May 7;299(17):2037-47
pubmed: 18460664
Am J Epidemiol. 2001 Apr 15;153(8):807-14
pubmed: 11296155
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
N Engl J Med. 2013 Jan 24;368(4):351-64
pubmed: 23343064
Am J Epidemiol. 2012 Apr 15;175(8):816-26
pubmed: 22396389
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1264-72
pubmed: 24740202
Am J Prev Med. 2014 Feb;46(2):e31-7
pubmed: 24439359

Auteurs

Maki Inoue-Choi (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Patricia Hartge (P)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Yikyung Park (Y)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

Christian C Abnet (CC)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Neal D Freedman (ND)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH